Word

BASILEA PHARMACEUTICA

Status

Pending

Status Code

734

Status Date

Wednesday, January 10, 2024

Serial Number

90269990

Mark Type

4000

Filing Date

Wednesday, October 21, 2020

Published for Opposition

Tuesday, May 4, 2021

Trademark Owner History

BASILEA PHARMACEUTICA INTERNATIONAL AG,ALLSCHWIL - 1st New Owner After Publication
Basilea Pharmaceutica International Ltd. - Owner At Publication

Classifications

5 Pharmaceutical and veterinary products and preparations for the treatment and prevention of dermatological conditions, namely, eczema, inflammation, infection, warts, psoriasis, aging of the skin, ultra violet radiation and cancer; Pharmaceutical and veterinary products and preparations for the treatment and prevention of infections caused by bacteria, fungi, viruses, and rheumatoid arthritis; Pharmaceutical and veterinary products and preparations for the treatment and prevention of diseases, disorders and conditions in the area of oncology; Pharmaceutical and veterinary products and preparations for the treatment and prevention of diseases, disorders and conditions in the area of gastroenterology; Pharmaceutical and veterinary products and preparations for the treatment and prevention of diseases, disorders and conditions in the area of neurology; Pharmaceutical and veterinary products and preparations for the treatment and prevention of diseases, disorders and conditions in the area of gynecology; Pharmaceutical and veterinary products and preparations for the treatment and prevention of diseases, disorders and conditions in the area of urology; Pharmaceutical and veterinary products and preparations for the treatment and prevention of diseases, disorders and conditions in the area of cardiology; Pharmaceutical and veterinary products and preparations for the treatment and prevention of diseases, disorders and conditions in the area of endocrinology; Pharmaceutical and veterinary products and preparations for the treatment and prevention of diseases, disorders and conditions in the area of nephrology; Pharmaceutical and veterinary products and preparations for the treatment and prevention of diseases, disorders and conditions in the area of hematology; Pharmaceutical and veterinary products and preparations for the treatment and prevention of diseases, disorders and conditions in the area of allergy; Pharmaceutical and veterinary products and preparations for the treatment and prevention of diseases, disorders and conditions in the area of immunology; Pharmaceutical and veterinary products and preparations for the treatment and prevention of diseases, disorders and conditions in the area of psychiatry; Pharmaceutical and veterinary products and preparations for the treatment and prevention of diseases, disorders and conditions in the area of anesthesiology; Pharmaceutical and veterinary products and preparations for the treatment and prevention of diseases, disorders and conditions in the area of rheumatology; diagnostic preparations for medical purposes; clinical medical reagents

1 Chemical substances for use in the manufacture of pharmaceutical preparations for the treatment of dermatological conditions, the treatment of infections and diseases and in the research and development of pharmaceuticals in the treatment of dermatological conditions, the treatment of infections and diseases; diagnostic preparations for scientific clinical use; diagnostic reagents for clinical or medical laboratory use

42 Research and development services for third parties in the field of chemical substances, pharmaceutical and veterinary products and preparations

"PHARMACEUTICA"

Trademark Events

Jan 11, 2024

Notice Of Approval Of Extension Request E-Mailed

Jan 10, 2024

Sou Extension 5 Granted

Dec 19, 2023

Sou Extension 5 Filed

Jan 10, 2024

Case Assigned To Intent To Use Paralegal

Dec 19, 2023

Sou Teas Extension Received

Jun 28, 2023

Automatic Update Of Assignment Of Ownership

Jun 22, 2023

Notice Of Approval Of Extension Request E-Mailed

Jun 20, 2023

Sou Extension 4 Granted

Jun 20, 2023

Sou Extension 4 Filed

Jun 20, 2023

Sou Teas Extension Received

Dec 7, 2022

Notice Of Approval Of Extension Request E-Mailed

Dec 5, 2022

Sou Extension 3 Granted

Dec 5, 2022

Sou Extension 3 Filed

Dec 5, 2022

Sou Teas Extension Received

Jun 22, 2022

Notice Of Approval Of Extension Request E-Mailed

Jun 20, 2022

Sou Extension 2 Granted

Jun 20, 2022

Sou Extension 2 Filed

Jun 20, 2022

Sou Teas Extension Received

May 27, 2022

Assigned To Examiner

Dec 4, 2021

Notice Of Approval Of Extension Request E-Mailed

Dec 2, 2021

Sou Extension 1 Granted

Dec 2, 2021

Sou Extension 1 Filed

Dec 2, 2021

Sou Teas Extension Received

Jun 29, 2021

Noa E-Mailed - Sou Required From Applicant

May 4, 2021

Official Gazette Publication Confirmation E-Mailed

May 4, 2021

Published For Opposition

Apr 14, 2021

Notification Of Notice Of Publication E-Mailed

Mar 29, 2021

Approved For Pub - Principal Register

Mar 29, 2021

Examiner's Amendment Entered

Mar 29, 2021

Notification Of Examiners Amendment E-Mailed

Mar 29, 2021

Examiners Amendment E-Mailed

Mar 29, 2021

Examiners Amendment -Written

Mar 22, 2021

Assigned To Examiner

Dec 10, 2020

New Application Office Supplied Data Entered

Oct 24, 2020

New Application Entered